Literature DB >> 28409447

Isolation of Peroxisomes from Mouse Brain Using a Continuous Nycodenz Gradient: A Comparison to the Isolation of Liver and Kidney Peroxisomes.

Miriam J Schönenberger1, Werner J Kovacs2.   

Abstract

In the central nervous system (CNS) peroxisomes are present in all cell types, namely neurons, oligodendrocytes, astrocytes, microglia, and endothelial cells. Brain peroxisomes are smaller in size compared to peroxisomes from other tissues and are therefore referred to as microperoxisomes. We have established a purification procedure to isolate highly purified peroxisomes from the central nervous system that are well separated from the endoplasmic reticulum and mitochondria and are free of myelin contamination. The major difficulty in purification of brain peroxisomes compared to peroxisomes from liver or kidney is the presence of large amounts of myelin in the CNS, which results in contamination of the subcellular fractions. Hence, the crucial step of the isolation procedure is the elimination of myelin by the use of a sucrose gradient, since without the elimination of myelin no significant enrichment of purified peroxisomes can be achieved. Another difficulty is that in brain tissue the abundance of peroxisomes decreases significantly during postnatal development. We provide a detailed protocol for the isolation of peroxisomes from mouse central nervous system as well as a protocol for the isolation of peroxisomes from the liver and kidney using a continuous Nycodenz gradient.

Entities:  

Keywords:  Brain; Central nervous system; Fractionation; Kidney; Liver; Microperoxisomes; Myelin; Nycodenz gradient; Peroxisomes

Mesh:

Substances:

Year:  2017        PMID: 28409447     DOI: 10.1007/978-1-4939-6937-1_2

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  2 in total

Review 1.  Peroxisomal Dysfunction and Oxidative Stress in Neurodegenerative Disease: A Bidirectional Crosstalk.

Authors:  Marc Fransen; Iulia Revenco; Hongli Li; Cláudio F Costa; Celien Lismont; Paul P Van Veldhoven
Journal:  Adv Exp Med Biol       Date:  2020       Impact factor: 2.622

2.  The differentially mitochondrial proteomic dataset in human ovarian cancer relative to control tissues.

Authors:  Xianquan Zhan; Tian Zhou; Na Li; Huanni Li
Journal:  Data Brief       Date:  2018-08-14
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.